A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

PHASE2RecruitingINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Cirrhotic Ascites

Interventions

DRUG

OrsHSA

OsrHSA a recombinant HSA, which was expressed and purified from the plant Oryza sativa

DRUG

HSA

Albutein® 20% (ALBUMIN HUMAN INFUSION 20% 50ML)

Trial Locations (1)

RECRUITING

First Hospital of Jilin University, Changchun